Author

L. M. Higa

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:imaging· 1 Approach:microscopy & imaging analysis· 1

Frequent Co-Authors

A. Tanuri· 2 shared F. L. Monteiro· 2 shared A. A. Stolet· 1 shared A. C. Oliveira· 1 shared A. M. O. Gomes· 1 shared C. H. Dumard· 1 shared C. Q. Sacramento· 1 shared E. L. Durigon· 1 shared

Activity by Year

2020-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. Tanuri

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Potent neutralizing equine antibodies raised against recombinant SARS-CoV-2 spike protein for COVID-19 passive immunization therapy

L. E. R. Cunha, A. A. Stolet, M. A. Strauch, V. A. R. Pereira, C. H. Dumard, A. M. O. Gomes, P. N. C. Souza, J. G. Fonseca, F. E. Pontes, L. G. R. Meirelles, J. W. M. Albuquerque, C. Q. Sacramento, N. Fintelman-Rodrigues, T. M. Lima, R. G. F. Alvim, , J. L. Silva

This study produces potent equine antibodies against SARS-CoV-2 spike protein with high neutralizing titers, supporting a clinical trial for passive immunization therapy.

bioRxiv · Aug 17, 2020 · PreprintImmunology

Ultrastructural analysis of SARS-CoV-2 interactions with the host cell via high resolution scanning electron microscopy

L. A. Caldas, F. A. Carneiro, L. M. Higa, F. L. Monteiro, G. P. da Silva, L. J. d. Costa, E. L. Durigon, A. Tanuri, W. de Souza

This paper uses high resolution scanning electron microscopy to examine SARS-CoV-2 interactions with Vero cells at 2 and 48 hours post-infection, revealing new structural insights into viral processing and transmission.

bioRxiv · Jun 10, 2020Microbiology